June 2026 GEA launched the CONRAD® pharmaceutical freeze dryer, a next-generation lyophilization platform featuring advanced automation, improved energy efficiency, and scalable GMP-compliant configurations for biologics and sterile injectable manufacturing. The system is designed to support pharmaceutical manufacturers in North America with higher production flexibility and optimized freeze-drying performance.
March 2026 Syntegon enhanced its Lyomax pharmaceutical freeze dryer platform by incorporating advanced Process Analytical Technology (PAT), automated loading/unloading systems, and digital process controls to improve lyophilization efficiency for commercial pharmaceutical production.
November 2025 SP Scientific introduced new capabilities for its VirTis freeze dryer portfolio, including enhanced automation, remote monitoring, and optimized cycle development features for pharmaceutical and biotechnology applications. The launch strengthens freeze-drying solutions for biologics, vaccines, and advanced therapies.
October 2025 GEA announced a collaboration with a major pharmaceutical manufacturer to deploy advanced pharmaceutical freeze-drying technology for sterile injectable drug production, focusing on improving manufacturing capacity, energy efficiency, and process reliability.